DART®-MS Analysis of Methamphetamine and Amphetamine in Urine Using BioSPME
材料
Standard
製品番号
詳細
価格
(±)-Amphetamine-d5 (deuterium label on ring) solution
100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®(±)-Amphetamine solution
1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®(±)-Methamphetamine-D5 solution
100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®(±)-Methamphetamine solution
1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®CONDITIONS
SPME fiber
BioSPME (SPME LC) Mixed Mode fiber
extraction
10 min with 1 mL sample
desorption process
Direct MS
detector
MS, Full scan 100-500 amu
詳細
アナリシスノート
BioSPME was used to determine the presence of methamphetamine and amphetamine in urine samples. Initial screening results can be obtained in less than 60 seconds by analyzing the extracted urine samples on a DART-MS system. By employing a fast and accurate screening method, the number of samples that require chiral separation can be reduced and laboratories can increase throughput and decrease costs associated with their drug screening programs.
法的情報
DART is a registered trademark of JEOL USA, Inc.